9-(2-hydroxy-3-nonyl)adenine has been researched along with Colitis in 3 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Colitis was induced by 2,4-dinitrobenzenesulfonic acid (DNBS)." | 3.80 | Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats. ( Antonioli, L; Awwad, O; Blandizzi, C; Brun, P; Caputi, V; Castagliuolo, I; Colucci, R; Fornai, M; Giron, MC; Giustarini, G; Pellegrini, C; Qesari, M; Scarpignato, C; Tuccori, M, 2014) |
| " In this study, the effects of 4-amino-2-(2-hydroxy-1-decyl)pyrazole[3,4-d]pyrimidine (APP; novel adenosine deaminase inhibitor), erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA; standard adenosine deaminase inhibitor), and dexamethasone were tested in rats with colitis induced by 2,4-dinitrobenzenesulfonic acid (DNBS)." | 3.74 | Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. ( Antonioli, L; Blandizzi, C; Breschi, MC; Colucci, R; Da Settimo, F; Del Taca, M; Duranti, E; Fornai, M; Ghisu, N; Kastsiuchenka, O; La Motta, C; Mugnaini, L; Natale, G; Vassalle, C; Virdis, A, 2007) |
| "Colitis was associated with decreased food intake and body weight, augmented spleen weight, and increased levels of colonic TNF-α, IL-6, and MDA." | 1.36 | The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. ( Antonioli, L; Awwad, O; Blandizzi, C; Colucci, R; Da Settimo, F; Duranti, E; Fornai, M; Ghisu, N; La Motta, C; Natale, G; Tuccori, M; Virdis, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonioli, L | 3 |
| Fornai, M | 3 |
| Awwad, O | 2 |
| Giustarini, G | 1 |
| Pellegrini, C | 1 |
| Tuccori, M | 2 |
| Caputi, V | 1 |
| Qesari, M | 1 |
| Castagliuolo, I | 1 |
| Brun, P | 1 |
| Giron, MC | 1 |
| Scarpignato, C | 1 |
| Blandizzi, C | 3 |
| Colucci, R | 3 |
| Ghisu, N | 2 |
| Da Settimo, F | 2 |
| La Motta, C | 2 |
| Natale, G | 2 |
| Duranti, E | 2 |
| Virdis, A | 2 |
| Kastsiuchenka, O | 1 |
| Vassalle, C | 1 |
| Mugnaini, L | 1 |
| Breschi, MC | 1 |
| Del Taca, M | 1 |
3 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Colitis
| Article | Year |
|---|---|
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.
Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Benzenesulfonates; Colitis; C | 2014 |
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Blotting, Western; Body Weigh | 2010 |
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Benzenesulfonates; Body Weigh | 2007 |